A hospital-acquired infection lawsuit is a medical malpractice claim filed when a patient contracts an infection while receiving care in a hospital or other healthcare facility, and that infection results from the healthcare provider’s failure to maintain proper safety standards. These lawsuits seek compensation for the additional suffering, medical expenses, and damages caused by preventable infections that patients acquired during their hospital stay. For example, a patient admitted for routine surgery could develop a surgical site infection (SSI) due to inadequate sterilization procedures or improper wound care, leading to extended hospitalization, systemic sepsis, and permanent complications that could have been avoided with proper infection control measures.
Hospital-acquired infections, also called healthcare-associated infections (HAIs), represent one of the most common and costly forms of medical negligence. According to the CDC, about 1 in 31 hospital patients has at least one healthcare-associated infection on any given day, and more than 680,000 infections occur annually across U.S. hospitals, resulting in billions in excess healthcare costs. With nearly 2 million people annually contracting healthcare-associated infections and approximately 100,000 deaths attributed to them, these cases form a significant portion of medical malpractice litigation.
Table of Contents
- How Prevalent Are Hospital-Acquired Infections and What Triggers Lawsuits?
- What Types of Hospital-Acquired Infections Lead to Successful Litigation?
- What Settlement and Verdict Amounts Can Patients Expect?
- How to Build a Successful Hospital-Acquired Infection Case
- What Challenges and Limitations Complicate HAI Litigation?
- Infection Control Standards and Breach of Duty
- Future Trends in Hospital-Acquired Infection Litigation
- Conclusion
How Prevalent Are Hospital-Acquired Infections and What Triggers Lawsuits?
The scale of hospital-acquired infections in the United States creates substantial opportunities for litigation. Federal surveillance conducted through the National Healthcare Safety Network (NHSN) tracks thousands of infections annually, with rates varying by region and facility type. In some healthcare areas, the prevalence reaches as high as 1 in 25 patients, compared to the national average of 1 in 31. These infections span multiple types: catheter-associated urinary tract infections (CAUTI), central line-associated bloodstream infections (CLABSI), methicillin-resistant Staphylococcus aureus (MRSA) infections, Clostridioides difficile (C.
difficile) infections, and surgical site infections following procedures like colon surgery. A lawsuit typically arises when evidence shows that healthcare providers breached the standard of care expected in their field. This breach must have directly caused the infection and resulting injuries. For instance, a patient developing a central line-associated bloodstream infection (CLABSI) due to contaminated catheter insertion or inadequate catheter maintenance protocols would have a viable claim if proper infection control procedures were not followed. The infection must cause measurable damages—extended hospital stays, additional surgeries, systemic sepsis, organ damage, or death—to justify legal action and compensation.
What Types of Hospital-Acquired Infections Lead to Successful Litigation?
The most litigated hospital-acquired infections share a common characteristic: they are substantially preventable through adherence to established clinical guidelines and infection control protocols. surgical site infections (SSIs) represent a significant category because they occur in a controlled environment where sterile technique is paramount. A surgeon who fails to maintain proper aseptic technique, a hospital that inadequately sterilizes surgical instruments, or a facility that allows post-operative wound contamination creates clear negligence. Central line-associated bloodstream infections (CLABSI) and catheter-associated urinary tract infections (CAUTI) also feature prominently in litigation because prevention protocols are well-established and relatively straightforward to implement.
These infections result from improper line insertion, inadequate daily site care, unnecessary prolonged catheterization, or breach of aseptic technique. Similarly, MRSA and C. difficile infections in hospital settings often indicate failures in contact precautions, hand hygiene, or environmental contamination control. A critical limitation in these cases is that proving causation can be complex—hospitals often argue that the patient’s underlying condition or immune status made infection inevitable, even with proper care, which can reduce settlement values significantly.
What Settlement and Verdict Amounts Can Patients Expect?
Hospital-acquired infection cases typically settle in the mid- to high-six-figure range, with many reaching seven figures depending on the severity of injury and the strength of evidence. The average settlement for HAI malpractice cases hovers around $250,000, though this average masks significant variation. A case involving a brief hospitalization, rapid diagnosis, and successful antibiotic treatment might settle for $100,000 to $300,000, while a case involving sepsis, organ failure, amputation, or prolonged ICU care can exceed $1 million.
Notable jury verdicts illustrate the upper range of potential damages. A $15 million verdict was awarded in a MRSA pneumonia case, while other high-stakes cases have produced verdicts exceeding $23 million. These awards reflect not just the cost of additional medical treatment—which can add at least $20,000 in hospital expenses for a single surgical site infection alone—but also non-economic damages for pain and suffering, permanent disability, and loss of life enjoyment. The variation between typical settlements ($250,000) and exceptional verdicts (millions) underscores the importance of case factors: the strength of negligence evidence, the severity of infection consequences, the patient’s age and prior health status, and the jurisdiction where the case is tried.
How to Build a Successful Hospital-Acquired Infection Case
Building a compelling hospital-acquired infection case requires thorough documentation and expert analysis. The foundation rests on establishing four elements: duty (the hospital and providers owed the patient a standard of care), breach (they failed to meet that standard), causation (the breach caused the infection), and damages (the infection caused measurable harm). Medical expert testimony is essential—experts in infectious disease, infection control, or surgical care must opine that the infection resulted from a deviation from established protocols.
Investigative strategy should focus on identifying specific breaches in infection control: Was proper hand hygiene maintained? Were invasive devices inserted using aseptic technique? Were contaminated surfaces cleaned appropriately? Were unnecessary devices removed promptly? Medical records, facility policies, infection control documentation, and incident reports form the evidentiary foundation. A comparison between a facility’s stated policies and actual practice often reveals negligence—for example, a hospital policy requiring daily assessment for central line necessity, but medical records showing no such assessments, demonstrates clear breach. The timeline of the infection’s onset, progression, and treatment also proves critical; an infection developing within 48 hours of a specific procedure points toward operative transmission, while later infections may suggest institutional contamination failures.
What Challenges and Limitations Complicate HAI Litigation?
Hospital-acquired infection cases face significant defensive challenges. Healthcare institutions argue that infections can occur despite proper care, particularly in immunocompromised or critically ill patients. Defense experts often contend that the patient’s underlying condition—diabetes, cancer, advanced age, or severe trauma—made infection statistically more likely regardless of preventive measures. This creates causation disputes that can reduce case value substantially. A patient admitted with septic shock and multiple comorbidities may struggle to prove that a particular breach caused a specific infection, even if facility protocols were deficient.
Another limitation involves the temporal difficulty in pinpointing precisely when an infection was acquired. A patient hospitalized for five days who develops symptoms ten days after discharge may have been exposed in the hospital but could argue transmission occurred in the community. Conversely, hospitals may argue that a symptom onset weeks after discharge indicates community-acquired rather than hospital-acquired infection. Insurance coverage also presents challenges—some healthcare facilities maintain strong litigation reserves and can afford aggressive defense, while others may be underinsured, complicating recovery. Additionally, some jurisdictions impose caps on non-economic damages or maintain strict comparative fault rules that reduce plaintiff awards, making identical clinical negligence worth substantially different amounts depending on geography.
Infection Control Standards and Breach of Duty
Successful litigation depends on clearly defining the standard of care through established guidelines. The CDC publishes evidence-based guidelines for preventing specific infections: hand hygiene protocols, personal protective equipment requirements, catheter care procedures, sterile technique standards, and environmental cleaning protocols. The Occupational Safety and Health Administration (OSHA) enforces bloodborne pathogen standards, while state licensing boards establish facility-specific requirements. When healthcare providers deviate from these guidelines, breach of duty becomes readily apparent.
A concrete example illustrates the concept: CDC guidelines recommend removing urinary catheters as soon as clinically feasible because prolonged catheterization increases infection risk exponentially. If a patient had a foley catheter in place for ten days post-operatively despite physician orders for removal at day three, and subsequently developed a CAUTI, the breach is straightforward. Medical records documenting when the catheter was placed, clinical notes justifying its continuation, and the date it was finally removed create a factual timeline supporting negligence. This contrasts with cases where proper protocols were followed but infection still occurred—the same clinical situation without the documentation gap would likely not support litigation.
Future Trends in Hospital-Acquired Infection Litigation
Hospital-acquired infection litigation is evolving as surveillance data improves and prevention strategies become more standardized. Recent CDC data shows that several infection types have declined: C. difficile infections decreased by 11%, CAUTI by 10%, CLABSI by 9%, and MRSA by 7% between 2023 and 2024. These reductions establish new baseline expectations—facilities failing to achieve these reductions may face increased scrutiny about their infection control protocols.
As prevention becomes more achievable, juries may hold hospitals to higher standards, viewing any significant infection outbreak as evidence of negligence rather than unavoidable complication. Emerging litigation will likely focus on institutional accountability rather than individual provider error. As infection control becomes increasingly systematized with computerized reminders, standardized checklists, and data tracking, failures become more clearly attributable to organizational policy deficiencies rather than isolated human mistakes. Hospitals with robust infection prevention programs demonstrating compliance data will defend cases more effectively than those unable to document systematic attention to infection control. This shift may increase settlement values for cases against poorly-equipped or understaffed facilities while reducing values against institutions with documented best-practice implementation.
Conclusion
Hospital-acquired infection lawsuits represent a significant area of medical malpractice litigation driven by the staggering prevalence of preventable infections in U.S. healthcare. With nearly 2 million people annually contracting healthcare-associated infections and average settlements around $250,000, these cases justify serious legal attention. The litigation depends fundamentally on documenting deviations from established infection control standards, proving those deviations caused the specific infection, and quantifying the damages resulting from additional medical harm.
If you or a family member contracted a hospital-acquired infection during a healthcare encounter, consulting with a medical malpractice attorney is the appropriate next step. An experienced attorney can review medical records, engage infectious disease experts, and determine whether the facility’s actions fell below the standard of care. Early legal consultation preserves evidence and establishes liability deadlines. Healthcare facilities and insurance carriers take these claims seriously because successful litigation demonstrates the importance of infection prevention—holding institutions accountable incentivizes system-wide improvements that protect future patients.